Danaparoid and renal failure Patient Reports February 10, 2010

Danaparoid Side Effects Report #6085320-X
Danaparoid side effect was reported by a Physician from FRANCE on Feb 13, 2009. Male patient, 80 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, femoral artery occlusion, haematoma, heparin-induced thrombocytopenia, multi-organ failure, peripheral ischaemia, renal failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, AMIODARONE, FUROSEMIDE, AUGMENTIN, ACETYLSALICYLATE LYSINE. Patient died.

Danaparoid Side Effects Report #5096633-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dehydration, hyperkalaemia, hypocholesterolaemia, leukocytosis, liver disorder, renal failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with CEFOZOPRAN HYDROCHLORIDE, VANCOMYCIN, BIAPENEM, TEICOPLANIN, MICAFUNGIN, PREDNISOLONE ACETATE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5030652-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 08, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dehydration, hyperkalaemia, hypoalbuminaemia, hypocholesterolaemia, leukocytosis, liver disorder, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with CEFOZOPRAN HYDROCHLORIDE, VANCOMYCIN, BIAPENEM, TEICOPLANIN, MICAFUNGIN, PREDNISOLONE ACETATE, PROPOFOL. Patient died.

Danaparoid Side Effects Report #5047256-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 22, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: catheter related complication, condition aggravated, fibrin d dimer increased, haemorrhage, pelvic fluid collection, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, TIENAM. Patient recovered.


Danaparoid Side Effects Report #5062421-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 20, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: fibrin d dimer increased, haematocrit decreased, haemoglobin decreased, haemorrhage, renal failure, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.

Danaparoid Side Effects Report #5030468-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemorrhage, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, BROMHEXINE HYDROCHLORIDE, DOPAMINE, DOBUTAMINE, NORADRENALINE, ALBUMIN, PRIMAXIN. Patient recovered.

Danaparoid Side Effects Report #5129253-1
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, haemorrhage subcutaneous, hepatic failure, multi-organ failure, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FUROSEMIDE, DOPAMINE, POTASSIUM CANRENOATE, CEFTAZIDIME, NAFAMOSTAT MESILATE. Patient died.

Danaparoid Side Effects Report #4707197-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on June 23, 2005. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dialysis , haematoma, haemoglobin decreased, lung disorder, pseudomonas infection, renal failure, shock. Danaparoid dosage: unknown. During the same period patient was treated with CEFEPIME HYDROCHLORIDE, AMIKACIN, NEFOPAM HYDROCHLORIDE, TRIMEBUTINE, METOCLOPRAMIDE, ACETAMINOPHEN, OMEPRAZOLE. Patient recovered.